|
1
|
McKenzie AJ, Campbell SL and Howe AK:
Protein kinase A activity and anchoring are required for ovarian
cancer cell migration and invasion. PLoS One. 6:e265522011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lorkova L, Pospisilova J, Lacheta J,
Leahomschi S, Zivny J, Cibula D, Zivny J and Petrak J: Decreased
concentrations of retinol-binding protein 4 in sera of epithelial
ovarian cancer patients: A potential biomarker identified by
proteomics. Oncol Rep. 27:318–324. 2012.
|
|
3
|
Phillips ML, Nudelman E, Gaeta FC, Perez
M, Singhal AK, Hakomori S and Paulson JC: ELAM-1 mediates cell
adhesion by recognition of a carbohydrate ligand, sialyl-Lex.
Science. 250:1130–1132. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Crucho CI, Correia-da-Silva P, Petrova KT
and Barros MT: Recent progress in the field of glycoconjugates.
Carbohydr Res. 402:124–132. 2015. View Article : Google Scholar
|
|
5
|
Wang ST, Liu JJ, Wang CZ, Lin B, Hao YY,
Wang YF, Gao S, Qi Y, Zhang SL and Iwamori M: Expression and
correlation of Lewisy antigen and TGF-β1 in ovarian epithelial
carcinoma. Oncol Rep. 27:1065–1071. 2012. View Article : Google Scholar
|
|
6
|
Liu J, Lin B, Hao Y, Qi Y, Zhu L, Li F,
Liu D, Cong J, Zhang S and Iwamori M: Lewisy antigen promotes the
proliferation of ovarian carcinoma-derived RMG-I cells through the
PI3K/Akt signaling pathway. J Exp Clin Cancer Res. 28:1542009.
View Article : Google Scholar
|
|
7
|
Iwamori M, Tanaka K, Kubushiro K, Lin B,
Kiguchi K, Ishiwata I, Tsukazaki K and Nozawa S: Alterations in the
glycolipid composition and cellular properties of ovarian
carcinoma-derived RMG-I cells on transfection of the alpha
1,2-fucosyltransferase gene. Cancer Sci. 96:26–30. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yan LM, Lin B, Zhu LC, Hao YY, Qi Y, Wang
CZ, Gao S, Liu SC, Zhang SL and Iwamori M: Enhancement of the
adhesive and spreading potentials of ovarian carcinoma RMG-1 cells
due to increased expression of integrin alpha5beta1 with the Lewis
Y-structure on transfection of the alpha1,2-fucosyltransferase
gene. Biochimie. 92:852–857. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kanekura T and Chen X: CD147/basigin
promotes progression of malignant melanoma and other cancers. J
Dermatol Sci. 57:149–154. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nabeshima K, Iwasaki H, Koga K, Hojo H,
Suzumiya J and Kikuchi M: Emmprin (basigin/CD147): Matrix
metalloproteinase modulator and multifunctional cell recognition
molecule that plays a critical role in cancer progression. Pathol
Int. 56:359–367. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gabison EE, Hoang-Xuan T, Mauviel A and
Menashi S: EMMPRIN/CD147, an MMP modulator in cancer, development
and tissue repair. Biochimie. 87:361–368. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen H, Wang L, Beretov J, Hao J, Xiao W
and Li Y: Co-expression of CD147/EMMPRIN with monocarboxylate
transporters and multiple drug resistance proteins is associated
with epithelial ovarian cancer progression. Clin Exp Metastasis.
27:557–569. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zou W, Yang H, Hou X, Zhang W, Chen B and
Xin X: Inhibition of CD147 gene expression via RNA interference
reduces tumor cell invasion, tumorigenicity and increases
chemosensitivity to paclitaxel in HO-8910 pm cells. Cancer Lett.
248:211–218. 2007. View Article : Google Scholar
|
|
14
|
Davidson B, Goldberg I, Berner A,
Kristensen GB and Reich R: EMMPRIN (extracellular matrix
metalloproteinase inducer) is a novel marker of poor outcome in
serous ovarian carcinoma. Clin Exp Metastasis. 20:161–169. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang W, Chang SB and Hemler ME: Links
between CD147 function, glycosylation, and caveolin-1. Mol Biol
Cell. 15:4043–4050. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hakuma N, Betsuyaku T, Kinoshita I, Itoh
T, Kaga K, Kondo S, Nishimura M and Dosaka-Akita H: High incidence
of extracellular matrix metalloproteinase inducer expression in
non-small cell lung cancers. Association with clinicopathological
parameters. Oncology. 72:197–204. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun J and Hemler ME: Regulation of MMP-1
and MMP-2 production through CD147/extracellular matrix
metalloproteinase inducer interactions. Cancer Res. 61:2276–2281.
2001.PubMed/NCBI
|
|
18
|
Jia L, Zhou H, Wang S, Cao J, Wei W and
Zhang J: Deglycosylation of CD147 down-regulates Matrix
Metalloproteinase-11 expression and the adhesive capability of
murine hepatocarcinoma cell HcaF in vitro. IUBMB Life. 58:209–216.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Prat J; FIGO Committee on Gynecologic
Oncology: Staging classification for cancer of the ovary, fallopian
tube, and peritoneum. Int J Gynaecol Obstet. 124:1–5. 2014.
View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta DeltaC(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Liotta LA and Stetler-Stevenson WG: Tumor
invasion and metastasis: An imbalance of positive and negative
regulation. Cancer Res. 51:s5054–s5059. 1991.
|
|
22
|
Zhang Q, Zhou J, Ku XM, Chen XG, Zhang L,
Xu J, Chen GS, Li Q, Qian F, Tian R, et al: Expression of CD147 as
a significantly unfavorable prognostic factor in hepatocellular
carcinoma. Eur J Cancer Prev. 16:196–202. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weidle UH, Scheuer W, Eggle D, Klostermann
S and Stockinger H: Cancer-related issues of CD147. Cancer Genomics
Proteomics. 7:157–169. 2010.PubMed/NCBI
|
|
24
|
Jin JS, Yao CW, Loh SH, Cheng MF, Hsieh DS
and Bai CY: Increasing expression of extracellular matrix
metalloprotease inducer In ovary tumors: Tissue microarray analysis
of immunostaining score with clinicopathological parameters. Int J
Gynecol Pathol. 25:140–146. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sillanpää S, Anttila M, Suhonen K,
Hämäläinen K, Turpeenniemi-Hujanen T, Puistola U, Tammi M, Sironen
R, Saarikoski S and Kosma VM: Prognostic significance of
extracellular matrix metalloproteinase inducer and matrix
metalloproteinase 2 in epithelial ovarian cancer. Tumour Biol.
28:280–289. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mandal PK and Turnbull WB: Studies on the
synthesis of Lewis-y oligosaccharides. Carbohydr Res.
346:2113–2120. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu L, Feng H, Jin S, Tan M, Gao S, Zhuang
H, Hu Z, Wang H, Song Z and Lin B: High expressions of BCL6 and
Lewisy antigen are correlated with high tumor burden and poor
prognosis in epithelial ovarian cancer. Tumour Biol.
39:10104283177116552017. View Article : Google Scholar
|
|
28
|
Kato N, Yuzawa Y, Kosugi T, Hobo A, Sato
W, Miwa Y, Sakamoto K, Matsuo S and Kadomatsu K: The E-selectin
ligand basigin/CD147 is responsible for neutrophil recruitment in
renal ischemia/reperfusion. J Am Soc Nephrol. 20:1565–1576. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Prieto PA, Larsen RD, Cho M, Rivera HN,
Shilatifard A, Lowe JB, Cummings RD and Smith DF: Expression of
human H-type alpha1,2-fucosyltransferase encoding for blood group
H(O) antigen in Chinese hamster ovary cells. Evidence for
preferential fucosylation and truncation of polylactosamine
sequences. J Biol Chem. 272:2089–2097. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Egawa N, Koshikawa N, Tomari T, Nabeshima
K, Isobe T and Seiki M: Membrane type 1 matrix metalloproteinase
(MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix
metalloproteinase inducer (EMMPRIN) fragment from tumor cells. J
Biol Chem. 281:37576–37585. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Belton RJ Jr, Chen L, Mesquita FS and
Nowak RA: Basigin-2 is a cell surface receptor for soluble basigin
ligand. J Biol Chem. 283:17805–17814. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Taylor PM, Woodfield RJ, Hodgkin MN,
Pettitt TR, Martin A, Kerr DJ and Wakelam MJ: Breast cancer
cell-derived EMMPRIN stimulates fibroblast MMP2 release through a
phospholipase A(2) and 5-lipoxygenase catalyzed pathway. Oncogene.
21:5765–5672. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sidhu SS, Mengistab AT, Tauscher AN,
LaVail J and Basbaum C: The microvesicle as a vehicle for EMMPRIN
in tumor-stromal interactions. Oncogene. 23:956–963. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li FF, Liu JJ, Liu DW, Lin B, Hao YY, Cong
JP, Zhu LC, Gao S, Zhang SL and Iwamori M: Lewis Y regulates
signaling molecules of the transforming growth factor β pathway in
ovarian carcinoma derived RMG-I cells. Int J Oncol. 40:1196–1202.
2012. View Article : Google Scholar
|
|
35
|
Tang Y, Kesavan P, Nakada MT and Yan L:
Tumor-stroma interaction: Positive feedback regulation of
extracellular matrix metalloproteinase inducer (EMMPRIN) expression
and matrix metalloproteinase-dependent generation of soluble
EMMPRIN. Mol Cancer Res. 2:73–80. 2004.PubMed/NCBI
|
|
36
|
Benting JH, Rietveld AG and Simons K:
N-Glycans mediate the apical sorting of a GPI-anchored,
raft-associated protein in Madin-Darby canine kidney cells. J Cell
Biol. 146:313–320. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang WJ, Li QQ, Xu JD, Cao XX, Li HX, Tang
F, Chen Q, Yang JM, Xu ZD and Liu XP: Interaction between CD147 and
P-glycoprotein and their regulation by ubiquitination in breast
cancer cells. Chemotherapy. 54:291–301. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Curtin KD, Meinertzhagen IA and Wyman RJ:
Basigin (EMMPRIN/CD147) interacts with integrin to affect cellular
architecture. J Cell Sci. 118:2649–2660. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Marieb EA, Zoltan-Jones A, Li R, Misra S,
Ghatak S, Cao J, Zucker S and Toole BP: Emmprin promotes
anchorage-independent growth in human mammary carcinoma cells by
stimulating hyaluronan production. Cancer Res. 64:1229–1232. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gao L, Yan L, Lin B, Gao J, Liang X, Wang
Y, Liu J, Zhang S and Iwamori M: Enhancive effects of Lewis y
antigen on CD44-mediated adhesion and spreading of human ovarian
cancer cell line RMG-I. J Exp Clin Cancer Res. 30:152011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gallagher SM, Castorino JJ and Philp NJ:
Interaction of mono-carboxylate transporter 4 with beta1-integrin
and its role in cell migration. Am J Physiol Cell Physiol.
296:C414–C421. 2009. View Article : Google Scholar
|
